Literature DB >> 11226974

Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey.

J A Mares-Perlman1, A I Fisher, R Klein, M Palta, G Block, A E Millen, J D Wright.   

Abstract

Relations of the carotenoids lutein and zeaxanthin in the diet and serum to photographic evidence of early and late age-related maculopathy (ARM) among persons over age 40 years (n = 8,222) were examined. Inverse relations of these carotenoids in the diet or serum to any form of ARM were not observed overall. There was a direct relation of dietary levels to one type of early ARM (soft drusen). However, relations differed by age and race. In the youngest age groups who were at risk for developing early (ages 40-59 years) or late (ages 60-79 years) ARM, higher levels of lutein and zeaxanthin in the diet were related to lower odds for pigmentary abnormalities, one sign of early ARM (odds ratio among persons in high vs. low quintiles = 0.1, 95 percent confidence interval: 0.1, 0.3) and of late ARM (odds ratio = 0.1, 95 percent confidence interval: 0.0, 0.9) after adjustment for age, gender, alcohol use, hypertension, smoking, and body mass index. Relations of these carotenoids to ARM may be influenced by age and race and require further evaluation in separate populations and in prospective studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226974     DOI: 10.1093/aje/153.5.424

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  63 in total

1.  Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.

Authors:  Qingning Bian; Shasha Gao; Jilin Zhou; Jian Qin; Allen Taylor; Elizabeth J Johnson; Guangwen Tang; Janet R Sparrow; Dennis Gierhart; Fu Shang
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

2.  Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study.

Authors:  Bénédicte M J Merle; Rachel E Silver; Bernard Rosner; Johanna M Seddon
Journal:  Am J Clin Nutr       Date:  2015-10-21       Impact factor: 7.045

Review 3.  Lutein and Zeaxanthin Isomers in Eye Health and Disease.

Authors:  Julie Mares
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

4.  Oxidative stress in ocular disease: does lutein play a protective role?

Authors:  Sylvia Santosa; Peter J H Jones
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

5.  Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).

Authors:  Burkhard Dasch; Andrea Fuhs; Joachim Schmidt; Thomas Behrens; Astrid Meister; Juergen Wellmann; Manfred Fobker; Daniel Pauleikhoff; Hans-Werner Hense
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

6.  In vivo macular pigment measurements: a comparison of resonance Raman spectroscopy and heterochromatic flicker photometry.

Authors:  R E Hogg; R S Anderson; M R Stevenson; M B Zlatkova; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

7.  Exposure-measurement error is frequently ignored when interpreting epidemiologic study results.

Authors:  Anne M Jurek; George Maldonado; Sander Greenland; Timothy R Church
Journal:  Eur J Epidemiol       Date:  2006-12-21       Impact factor: 8.082

Review 8.  [Vitamins for the eyes? Risks and opportunities for physician and patient].

Authors:  R Grossklaus; K J Henning
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

9.  Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative.

Authors:  Niyati Parekh; Rickie P Voland; Suzen M Moeller; Barbara A Blodi; Cheryl Ritenbaugh; Richard J Chappell; Robert B Wallace; Julie A Mares
Journal:  Arch Ophthalmol       Date:  2009-11

10.  The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

Authors:  Emily Y Chew; Traci Clemons; John Paul SanGiovanni; Ronald Danis; Amitha Domalpally; Wendy McBee; Robert Sperduto; Frederick L Ferris
Journal:  Ophthalmology       Date:  2012-07-26       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.